Icotinib and rh-endostatin as first line therapy in advanced non small cell line cancer patients harboring activating epidermal growth factor receptor mutations. This is an ASCO Meeting Abstract from ...
Measuring the lymphocytes — white blood cells that fight infection — in a patient’s blood can be used to predict outcomes in non-Hodgkin lymphoma patients who receive CAR T-cell therapy, according to ...
Use of maintenance rituximab (R) in the United States following R-based induction for follicular lymphoma (FL). 18F-fluorodeoxglucose (FDG) positron emission tomography (PET) versus FLIPI as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results